Preventive use of a topical anti-inflammatory glucocorticoid in atopic dogs without clinical sign of otitis does not affect ear canal microbiota and mycobiota
Preventive use of a topical anti-inflammatory glucocorticoid in atopic dogs without clinical sign of otitis does not affect ear canal microbiota and mycobiota.pdf
Canine otitis externa; Next generation sequencing; topical anti-inflammatory glucocorticoid
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Léonard, Caroline ; Université de Liège - ULiège > Département d'Ens. et de Clinique des animaux de Compagnie > Dermatologie des animaux de compagnie
Taminiau, Bernard ; Université de Liège - ULiège > Département de sciences des denrées alimentaires (DDA) > Microbiologie des denrées alimentaires
Ngo, Jérôme
Fantini, Oscar
Daube, Georges ; Université de Liège - ULiège > Département de sciences des denrées alimentaires (DDA) > Microbiologie des denrées alimentaires
Fontaine, Jacques ; Université de Liège - ULiège > Département d'Ens. et de Clinique des animaux de Compagnie > Dermatologie des animaux de compagnie
Language :
English
Title :
Preventive use of a topical anti-inflammatory glucocorticoid in atopic dogs without clinical sign of otitis does not affect ear canal microbiota and mycobiota
Angus JC. Otic cytology in health and disease. Vet Clin North Am Small Anim Pract 2004; 34: 411–424.
Santoro D, Marsella R, Pucheu-Haston CM et al. Review: pathogenesis of canine atopic dermatitis: skin barrier and host–micro-organism interaction. Vet Dermatol 2015; 26: 84–e25.
Miller WH, Griffin CE, Campbell KL. Muller and Kirk’s Small Animal Dermatology, 7th edition. St Louis, MO: Elsevier Mosby, 2013; 724–773.
Sim JXF, Khazandi M, Chan WY et al. Antimicrobial activity of thyme oil, oregano oil, thymol and carvacrol against sensitive and resistant microbial isolates from dogs with otitis externa. Vet Dermatol 2019; 30: 524–e159.
Linek M, Favrot C. Impact of canine atopic dermatitis on the health-related quality of life of affected dogs and quality of life of their owners. Vet Dermatol 2010; 21: 456–462.
Wollenberg A, Reitamo S, Atzori F et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008; 63: 742–750.
Bensignor E, Germain PA, Roussel A et al. Safety of a proactive therapy with hydrocortisone aceponate (Cortavance®) in ears to reduce the risk of recurrence of otitis externa in atopic dogs: a retrospective study. Free communication at Southern European Veterinary Congress. Barcelona: 2017.
Kong HH, Oh J, Deming C et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012; 22: 850–859.
Gonzalez ME, Schaffer JV, Orlow SJ et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol 2016; 75: 481–493.e8.
Ngo J, Taminiau B, Fall PA et al. Ear canal microbiota – a comparison between healthy dogs and atopic dogs without clinical signs of otitis externa. Vet Dermatol 2018; 29: 425–e140.
Korbelik J, Singh A, Rousseau J et al. Characterization of the otic bacterial microbiota in dogs with otitis externa compared to healthy individuals. Vet Dermatol 2019; 30: 228–e70.
Bradley CW, Lee FF, Rankin SC et al. The otic microbiota and mycobiota in a referral population of dogs in eastern USA with otitis externa. Vet Dermatol 2020; 31: 225–e49.
Graham-Mize CA, Rosser EJ. Comparison of microbial isolates and susceptibility patterns from the external ear canal of dogs with otitis externa. J Am Anim Hosp Assoc 2004; 40: 102–108.
Favrot C, Steffan J, Seewald W et al. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol 2010; 21: 23–30.
Nuttall T, Bensignor E. A pilot study to develop an objective clinical score for canine otitis externa. Vet Dermatol 2014; 25: 530–537, e91–2.
Rodriguez C, Taminiau B, Korsak N et al. Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home. BMC Microbiol 2016; 16: 229.
Schloss PD, Westcott SL, Ryabin T et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009; 75: 7,537–7,541.
Edgar RC, Haas BJ, Clemente JC et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 2011; 27: 2,194–2,200.
Quast C, Pruesse E, Yilmaz P et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 2012; 41: D590–D596.
Misic AM, Davis MF, Tyldsley AS et al. The shared microbiota of humans and companion animals as evaluated from Staphylococcus carriage sites. Microbiome 2015; 3: 2.
Koljalg U, Nilsson RH, Abarenkov K et al. Towards a unified paradigm for sequence-based identification of fungi. Mol Ecol 2013; 22: 5,271–5,277.
Gower JC. Some distance properties of latent root and vector methods used in multivariate analysis. Biometrika 1966; 53: 325–338.
Meason-Smith C, Diesel A, Patterson AP et al. Characterization of the cutaneous mycobiota in healthy and allergic cats using next generation sequencing. Vet Dermatol 2017; 28: 71–e17.
Meason-Smith C, Diesel A, Patterson A et al. What is living on your dog’s skin? Characterization of the canine cutaneous mycobiota and fungal dysbiosis in canine allergic dermatitis. FEMS Microbiol Ecol 2015; 91: fiv139.
Rodrigues Hoffmann A, Patterson AP, Diesel A et al. The skin microbiome in healthy and allergic dogs. PLoS One 2014; 9: e83197.
Chermprapai S, Ederveen THA, Broere F et al. The bacterial and fungal microbiome of the skin of healthy dogs and dogs with atopic dermatitis and the impact of topical antimicrobial therapy, an exploratory study. Vet Microbiol 2019; 229: 90–99.
Bradley CW, Morris DO, Rankin SC et al. Longitudinal evaluation of the skin microbiome and association with microenvironment and treatment in canine atopic dermatitis. J Invest Dermatol 2016; 136: 1,182–1,190.
Bannoehr J, Guardabassi L. Staphylococcus pseudintermedius in the dog: taxonomy diagnostics, ecology, epidemiology and pathogenicity. Vet Dermatol 2012; 23: 253–266, e51–2.
Barnard N, Foster A. Pseudomonas otitis in dogs: A GP’s guide to treatment. In Pract 2017; 39: 386–398.
Paterson S. Discovering the causes of otitis externa. In Pract 2016; 38: 7–11.
Campbell JJ, Coyner KS, Rankin SC et al. Evaluation of fungal flora in normal and diseased canine ears. Vet Dermatol 2010; 21: 619–625.
Lourenço AM, Schmidt V, São Braz B et al. Efficacy of proactive long-term maintenance therapy of canine atopic dermatitis with 0.0584% hydrocortisone aceponate spray: a double-blind placebo controlled pilot study. Vet Dermatol 2016; 27: 88–92.e25.
Sauvé F. Use of topical glucocorticoids in veterinary dermatology. Can Vet J 2019; 60: 785–788.
Nam EH, Park SH, Jung JY et al. Evaluation of the effect of a 0.0584% hydrocortisone aceponate spray on clinical signs and skin barrier function in dogs with atopic dermatitis. J Vet Sci 2012; 13: 187–191.
Cole LK, Podell M, Kwochka KW. Impedance audiometric measurements in clinically normal dogs. Am J Vet Res 2000; 61: 442–445.
Forsythe WB. Tympanographic volume measurements of the canine ear. Am J Vet Res 1985; 46: 1,351–1,353.
Wollenberg A, Bieber T. Proactive therapy of atopic dermatitis – an emerging concept. Allergy 2009; 64: 276–278.
Widmer G, Ferrer L, Favrot C et al. Glucocorticosteroids and ciclosporin do not significantly impact canine cutaneous microbiota. BMC Vet Res 2018; 14: 51.
Marcia MK, Olivry T. The influence of mometasone furoate ear solution on intradermal test immediate reactions in dogs with atopic dermatitis. Vet Dermatol 2015; 26: 31–34, e9–10.
Ghubash R, Marsella R, Kunkle G. Evaluation of adrenal function in small-breed dogs receiving otic glucocorticoids. Vet Dermatol 2004; 15: 363–368.
Reiger M, Traidl-Hoffmann C, Neumann AU. The skin microbiome as a clinical biomarker in atopic eczema: Promises, navigation, and pitfalls. J Allergy Clin Immunol 2020; 145: 93–96.
Meisel JS, Hannigan GD, Tyldsley AS et al. Skin microbiome surveys are strongly influenced by experimental design. J Invest Dermatol 2016; 136: 947–956.
